Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

shutterstock_360472550

MSD teams up with Harvard University to discover novel immune system pathways to fight cancer

August 13, 2019 Manufacturing and Production, Research and Development Cancer, Harvard, MSD, Merck, immuno-oncology, oncology, pharma

A new partnership between MSD and Harvard University hopes to combine the expertise of both parties to carve a path …
News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Camurus’ weekly/monthly opioid dependence injection accepted in Scotland for NHS use

August 13, 2019 Manufacturing and Production, Sales and Marketing Camurus, NHS, Scotland, nhs scotland, opioid dependence, opioids, pharma

The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous injection) from Swedish pharma …
News
bacteria-163711_960_720

Chlamydia vaccine proves safe in Phase 1 trial

August 13, 2019 Manufacturing and Production chlamydia, clinicla trials, infectious diseases, pharma, vaccines

A chlamydia vaccine has shown to be safe in a Phase 1 clinical trial, according to a study published in …
News
14712294170_aaaf8f499d_z

Ebola drugs prove 90% effective in clinical trial in DRC

August 13, 2019 Manufacturing and Production, Research and Development Congo, DRC, Ebola, clinical trials, infectious diseases, niaid, pharma

Health professionals in the Democratic Republic of Congo (DRC) are now offering two experimental drugs to people infected with Ebola, …
News
vertex-headquarters

Scotland turns down Vertex’s Orkambi

August 13, 2019 Manufacturing and Production Orkambi, SMC, Scotland, Vertex, cystic fibrosis, pharma

The Scottish Medicines Consortium (SMC) has turned down Vertex’ cystic fibrosis drug Orkambi on the grounds that it is not …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

August 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, CAR T, CAR-T, Eli Lilly, Lexicon, Medicare, Novartis, Pfizer, Sanofi, pharma

This week’s top story covered the scandal surrounding Novartis over its covering up of faulty data from the FDA. The …
News
troy_robinson

Troy Robinson promoted to managing director of Chugai Pharma Europe

August 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Troy Robinson has been taken on as the new managing director of Chugai Pharma Europe. Mike Crosher will succeed him …
Appointment
lilly_building_with_american_flag_web

Lilly’s Emgality smashes all Phase 3 endpoints in migraine sub-population

August 6, 2019 Manufacturing and Production, Research and Development Eli Lilly, Emgality, migraine, pharma

New Phase 3 data have been revealed on Eli Lilly’s Emgality (galcanezumab-gnlm), detailing its success in meeting all of its …
News
nice_new_london_office_internal_2_8

NICE reject Clovis Oncology’s ovarian cancer drug Rubraca

August 6, 2019 Manufacturing and Production NHS, NICE, Rubraca, UK, guidance, pharma

Britain’s cost-effectiveness body NICE has chosen not to recommend Clovis Oncology’s cancer drug Rubraca (rucaparib). On 6 August, NICE issued …
News

Takeda signs deal with Sosei Heptares worth $1.2 billion

August 6, 2019 Manufacturing and Production GPCR, Sosei Heptares, Takeda, pharma, sosei

Takeda has entered into a partnership with Sosei Heptares to develop drugs that modulate G protein-coupled receptor (GPCR) targets. The …
News

Sanofi’s Dupixent extended in Europe to cover adolescents in atopic dermatitis

August 6, 2019 Manufacturing and Production, Sales and Marketing EU, Europe, Sanofi, atopic dermatits, pharma

Sanofi has announced that European Commission (EC) has chosen to extend the marketing approval of its interleukin-4 (IL-4) and interleukin-13 …
News

Pfizer’s sickle cell drug flops at Phase 3 trial

August 6, 2019 Manufacturing and Production, Sales and Marketing Pfizer, Sickle cell, clinical trials, pharma, reset

Pfizer has said its sickle cell drug rivipansel failed to meet its primary endpoint or key secondary endpoints in a …
News
vaila_morrison

Living with a rare genetic neurodevelopmental disorder

August 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KAT6A, feature, patient experience, pharma, rare disease

Vaila Morrison’s daughter Eilidh was born with the ultra-rare condition KAT6A. As a designer and architect by profession, Vaila told …
Feature
shutterstock_141299494

Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages

August 2, 2019 Manufacturing and Production, Medical Communications Cancer, NHS, UK, brexit, pharma

Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris …
News
dr_wajid_hussain

Dr Wajid Hussain appointed new clinical director for digital health at RCP

August 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IT, RCP, Royal College of Physicians, digital health, pharma

The Royal College of Physicians (RCP) has appointed Dr Wajid Hussain as its new clinical director for digital health. Dr …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026